Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).
作者信息
Svoboda D J, Azarnoff D L
出版信息
J Cell Biol. 1966 Aug;30(2):442-50. doi: 10.1083/jcb.30.2.442.
Abstract
摘要
相似文献
1
Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).肝脏微体对降血脂药氯苯丁酯（CPIB）的反应。
J Cell Biol. 1966 Aug;30(2):442-50. doi: 10.1083/jcb.30.2.442.
2
Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.实验性改变细胞中的微体。II. 微体增殖与内分泌腺的关系。
J Cell Biol. 1969 Mar;40(3):734-46. doi: 10.1083/jcb.40.3.734.
3
Microbodies in experimentally altered cells.实验性改变细胞中的微体。
J Cell Biol. 1967 Oct;35(1):127-52. doi: 10.1083/jcb.35.1.127.
4
5
Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.新型降血脂药物萘酚平诱导肝脏中微体增殖：与氯苯丁酯的比较。
Biochem Biophys Res Commun. 1973 May 15;52(2):537-43. doi: 10.1016/0006-291x(73)90745-6.
6
[Induction of fatty acid oxidation in peroxisomes of rat liver by magnesium-4 chlorophenoxyisobutyrate (Mg-CPIB)].[4-氯苯氧异丁酸镁（Mg-CPIB）对大鼠肝脏过氧化物酶体中脂肪酸氧化的诱导作用]
Arzneimittelforschung. 1979;29(8):1132-4.
7
8
Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.萘酚平诱导大鼠和小鼠肝脏微体（过氧化物酶体）增殖及过氧化氢酶合成。反应无性别差异。
J Cell Biol. 1974 May;61(2):344-58. doi: 10.1083/jcb.61.2.344.
9
Further evidence to suggest that microbodies do not exist as individual entities.进一步的证据表明，微体并非以独立实体的形式存在。
Am J Pathol. 1973 Mar;70(3):421-38.
10
Influence of a terminal period of fasting on the serum and tissue lipid effects of ethyl chlorophenoxyisobutyrate (CPIB).禁食末期对氯苯丁酯（CPIB）血清及组织脂质效应的影响。
Metabolism. 1968 Aug;17(8):681-9. doi: 10.1016/0026-0495(68)90052-8.
引用本文的文献
1
Phosphatidylethanolamine homeostasis under conditions of impaired CDP-ethanolamine pathway or phosphatidylserine decarboxylation.在CDP-乙醇胺途径受损或磷脂酰丝氨酸脱羧的情况下，磷脂酰乙醇胺的稳态。
Front Nutr. 2023 Jan 5;9:1094273. doi: 10.3389/fnut.2022.1094273. eCollection 2022.
2
Autophagic degradation of peroxisomes in mammals.哺乳动物中过氧化物酶体的自噬降解
Biochem Soc Trans. 2016 Apr 15;44(2):431-40. doi: 10.1042/BST20150268.
3
Peroxisome-mitochondria interplay and disease.过氧化物酶体与线粒体的相互作用及疾病
J Inherit Metab Dis. 2015 Jul;38(4):681-702. doi: 10.1007/s10545-015-9819-7. Epub 2015 Feb 17.
4
Simultaneous live-imaging of peroxisomes and the ER in plant cells suggests contiguity but no luminal continuity between the two organelles.在植物细胞中同时对过氧化物酶体和内质网进行活体成像表明，这两种细胞器是相邻的，但它们的腔隙并不连续。
Front Physiol. 2013 Jul 24;4:196. doi: 10.3389/fphys.2013.00196. eCollection 2013.
5
Tissue-specific differential induction of duplicated fatty acid-binding protein genes by the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio).组织特异性差异诱导过氧化物酶体增殖剂，氯贝酸，在斑马鱼（Danio rerio）中的重复脂肪酸结合蛋白基因。
BMC Evol Biol. 2012 Jul 9;12:112. doi: 10.1186/1471-2148-12-112.
6
Peroxisome proliferator-activated receptors and hepatitis C virus.过氧化物酶体增殖物激活受体与丙型肝炎病毒。
Therap Adv Gastroenterol. 2011 Nov;4(6):419-31. doi: 10.1177/1756283X11405251.
7
Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis.增强对氯贝特诱导肝癌发生敏感性的大鼠肝星状细胞减少。
Cancer Sci. 2011 Apr;102(4):735-41. doi: 10.1111/j.1349-7006.2011.01856.x. Epub 2011 Feb 10.
8
The Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease.核受体PPARγ作为阿尔茨海默病脑血管和脑功能障碍的治疗靶点
Front Aging Neurosci. 2010 May 21;2. doi: 10.3389/fnagi.2010.00021. eCollection 2010.
9
Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens.谷胱甘肽 S-转移酶 A4 是氯贝酸和遗传毒性致癌剂诱导大鼠肝灶的阳性标志物。
Cancer Sci. 2010 May;101(5):1093-8. doi: 10.1111/j.1349-7006.2010.01508.x. Epub 2010 Jan 22.
10
The peroxisome: still a mysterious organelle.过氧化物酶体：仍是一个神秘的细胞器。
Histochem Cell Biol. 2008 Apr;129(4):421-40. doi: 10.1007/s00418-008-0396-9. Epub 2008 Feb 15.
本文引用的文献
1
The Fine Structure of the Parenchymal Cell of the Normal Rat Liver: I. General Observations.正常大鼠肝脏实质细胞的精细结构：I. 一般观察。
Am J Pathol. 1965 May;46(5):691-755.
2
Simple methods for "staining with lead" at high pH in electron microscopy.电子显微镜中在高pH值下“铅染色”的简单方法。
J Biophys Biochem Cytol. 1961 Dec;11(3):729-32. doi: 10.1083/jcb.11.3.729.
3
NON-MITOCHONDRIAL OXIDIZING PARTICLES (MICROBODIES) IN RAT LIVER AND KIDNEY AND IN TETRAHYMENA PYRIFORMIS.大鼠肝脏、肾脏及梨形四膜虫中的非线粒体氧化颗粒（微体）
Biochem Biophys Res Commun. 1965 Jun 18;20:53-9. doi: 10.1016/0006-291x(65)90949-6.
4
STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).氯贝丁酯（安妥明）的研究。
Metabolism. 1965 Sep;14:959-65. doi: 10.1016/0026-0495(65)90111-3.
5
HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.大鼠中氯苯氧异丁酸乙酯（CPIB）导致的低脂血症和肝肿大
J Lab Clin Med. 1964 Oct;64:634-42.
6
ULTRASTRUCTURAL CHANGES PRODUCED BY PROTEIN AND RELATED DEFICIENCIES IN THE RAT LIVER.蛋白质及相关缺乏症在大鼠肝脏中引起的超微结构变化。
Am J Pathol. 1964 Sep;45(3):353-79.
7
URICASE: LOCALIZATION IN HEPATIC MICROBODIES.尿酸氧化酶：在肝脏微体中的定位
Science. 1964 Dec 4;146(3649):1316-8. doi: 10.1126/science.146.3649.1316.
8
EXPERIMENTAL STUDIES OF THE TOXICITY OF ATROMID WITH PARTICULAR REFERENCE TO FINE STRUCTURAL CHANGES IN THE LIVERS OF RODENTS.安妥明毒性的实验研究，特别涉及啮齿动物肝脏的精细结构变化
J Atheroscler Res. 1963 Sep-Dec;3:729-36. doi: 10.1016/s0368-1319(63)80059-9.
9
THE EFFECT OF ATROMID ON ARTERIAL DISEASE INDUCED BY SEMI-SYNTHETIC DIET IN THE RABBIT.安妥明对家兔半合成饮食诱发的动脉疾病的影响。
J Atheroscler Res. 1963 Sep-Dec;3:716-24. doi: 10.1016/s0368-1319(63)80057-5.
Zotero 插件